Evofem Biosciences, Inc. (NASDAQ:EVFM – Get Free Report) passed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $0.01 and traded as high as $0.01. Evofem Biosciences shares last traded at $0.01, with a volume of 172,262 shares.
Evofem Biosciences Stock Down 10.2 %
The firm has a market capitalization of $997,532.80, a price-to-earnings ratio of -0.01 and a beta of -0.74. The company’s 50 day moving average price is $0.01 and its 200 day moving average price is $0.01.
Evofem Biosciences Company Profile
Evofem Biosciences, Inc, a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100 for the prevention of chlamydia and gonorrhea in Women, and EVO200 for the prevention of recurrent bacterial vaginosis.
See Also
- Five stocks we like better than Evofem Biosciences
- How to Invest in Biotech Stocks
- 3 Buyable Stocks With Solid Bottoms Ready to Rebound
- What is a SEC Filing?
- Advantage+ Shopping: Meta’s Fast Growing $20 Billion AI-Ads Star
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Robotaxi News: What Tesla and Lyft Headlines Mean for Shares
Receive News & Ratings for Evofem Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evofem Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
